Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration

Ophthalmologica

Volumn 220, Issue 1, 2005, Pages 12-16

  Baskol, Gulden ^a   Karakucuk, Sarper ^a   Oner, Ayse Ozturk ^a   Baskol, Mevlut ^a   Kocer, Derya ^a   Mirza, Ertugrul ^a   Saraymen, Recep ^a   Üstdal, Muzaffer ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Age related macular degeneration; Malondialdehyde; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PATHOGENESIS; RETINA MACULA AGE RELATED DEGENERATION; SPECTROPHOTOMETRY;

AGED; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPID PEROXIDATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; SPECTROPHOTOMETRY;

EID: 29244481127     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089269     Document Type: Article

References (47)

1. Klein R, Klein BE, Jensen SC, Meuer SM: The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
2. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R: An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-374.
3. Vingerling JR, Hofman A, Grobbee DE, de Jong PT: Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 1996;114:1193-1196.
4. Christen WG Jr: Antioxidants and eye disease. Am J Med 1994;97:14S-17S.
5. Vinderling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT: Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404-409.
6. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M: Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805-1807.
7. Smith W, Mitchell P, Leeder SR, Wang JJ: Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583-587.
8. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidant, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-7922.
9. Harman D: Aging: phenomena and theories. Ann NY Acad Sci USA 1998;854:1-7.
10. Cai J, Nelson KC, Wu M, Stemberg P Jr, Jones DP: Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000;19:205-221.
11. De La Paz MA, Anderson RE: Lipid peroxidation in rod outer segments. Role of hydroxyl radical and lipid hydroperoxides. Invest Ophthalmol Vis Sci 1992;33:2091-2096.
12. Young RW: Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31:291-306.
13. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO: Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988;128:700-710.
14. Taylor HR: Ultraviolet radiation and eye: an epidemiologic study. Trans Am Ophthalmol Soc 1989;87:802-853.
15. Gerster H: Review: antioxidant protection of the ageing macula. Age Ageing 1991;20:60-69.
16. Gottsch JD, Pou S, Bynoe LA, ROMen GM: Hematogenous photosensitization: a mechanism for the development of age-related macular degeneration. Invest Ophahalmol Vis Sci 1990;31:1674-1682.
17. La Du BN, Adkins CL, Kuo DL, Lipsig D: Studies on human serum paraoxonase/arylesterase. Chem Biol Interact 1993;87:25-34.
18. La Du BN: Structural and functional diversity of paraoxonases. Nat Med 1996;2:1186-1187.
19. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA: Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996;7:69-76.
20. Nayak DU, Karmen C, Frishman WH, Vakili BA: Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease. Heart Dis 2001;3:28-45.
21. Draper HH, Hadley M: A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica 1990;20:901-907.
22. Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J: Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998; 106(suppl 5):1229-1234.
23. Jain SK: Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 1988;937:205-210.
24. Eckerson HW, Romson J, Wyte C, La Du BN: The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1983;35:214-227.
25. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721-724.
26. Coudray C, Roussel AM, Arnaud J, Favier A: Selenium and antioxidant vitamin and lipidoperoxidation levels in preaging French population. EVA Study Group. Etude de vieillissement artériel. Biol Trace Elem Res 1997;57:183-190.
27. Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, Ozerol E: Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 2003;106:129-136.
28. Prashar S, Pandav SS, Gupta A, Nath R: Antioxidant enzymes in RBCs as a biological index of age related macular degeneration. Acta Ophthalmol (Copenh) 1993;71:214-218.
29. Totan Y, Cekic O, Borazan M, Uz E, Sogut S, Akyol O: Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol 2001;85:1426-1428.
30. Yildirim O, Ates NA, Tamer L, Muslu N, Ercan B, Atik U, Kanik A: Changes in antioxidant enzyme activity and malondialdehyde level in patients with age-related macular degeneration. Ophthalmologica 2004;218:202-206.
31. Nowak M, Swietochowska E, Wielkoszynski T, Marek B, Karpe J, Gorski J, Glogowska-Szelag J, Kos-Kudla B, Ostrowska Z: Changes in blood antioxidants and several lipid peroxidation products in women with age-related macular degeneration. Eur J Ophthalmol 2003;13:281-286.
32. Fliesler SJ, Anderson RE: Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983;22:79-131.
33. Ito T, Nakano M, Yamamoto Y, Hiramitsu T, Mizuno Y: Hemoglobin-induced lipid peroxidation in the retina: a possible mechanism for macular degeneration. Arch Biochem Biophys 1995;316:864-872.
34. Winkler BS, Boulton ME, Gottsch JD, Sternberg P: Oxidative damage and age-related macular degeneration. Mol Vis 1990;5:32-43.
35. Snodderly DM: Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62:1448S-1461S.
36. Liang FQ, Godley BF: Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003;76:397-403.
37. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
38. Srivastava S, Chandra A, Bhatnagar A, Srivastava SK, Ansari NH: Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem Biophys Res Commun 1995;217:741-746.
39. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995;36:1271-1279.
40. Jin GF, Hurst JS, Godley BF: Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium. Curr Eye Res 2001;23:11-19.
41. Gaillard ER, Atherton SJ, Eldred G, Dillon J: Photophysical studies on human retinal lipofuscin. Photochem Photobiol 1995;61:448-453.
42. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T: Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 1995;270:18825-18830.
43. Kopitz J, Holz FG, Kaemmerer E, Schutt F: Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie 2004;86:825-831.
44. Ikeda T: The pathogenesis of vitreoretinal diseases from the standpoint of molecular biology. Nippon Ganka Gakkai Zasshi 2003;107:785-812.
45. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B: Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.
46. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-1590.
47. Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y, Koizumi K, Kinoshita S: Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 2001;132:191-195.